Daniel Tzivoni
Wolfson Medical Center
2 Papers
11 Citations
Daniel Tzivoni is an academic researcher from Wolfson Medical Center. The author has contributed to research in topics: Myocardial infarction & Bezafibrate. The author has an hindex of 2, co-authored 2 publications. Previous affiliations of Daniel Tzivoni include Sheba Medical Center.
Chat about Author
Papers
On-Site Catheterization Laboratory and Prognosis After Acute Myocardial Infarction
Solomon Behar,Hanoch Hod,Boaz Benari,Ron Narinsky,Hana Pauzner,Eldad Rechavia,Hedy E. Faibel,Amos Katz,Arie Roth,Ehud Goldhammer,Nahum A. Freedberg,Natan Rougin,Oscar H. Kracoff,Chen Shapira,Jamal Jafari,Chaim Lotan,Fatchy Daka,Shmuel Gottlieb,Tedi Weiss,Menahem Kanetti,Mark Klutstein,Leonid Rudnik,Eddy Barasch,Nabil Mahul,David S. Blondheim,Alen Gelvan,Gabriel I. Barbash,Zwi Schlesinger,Leonardo Reisin,Samuel Sclarovsky,Shlomo Stern,Edward G. Abinader,Bazel Luis,Abraham Palant,Tiberiu Rosenfeld,Mervyn Gotesman,Izhar Zahavi,Benyamin Pelled,Shlomo Laniado,Avraham Caspi,Daniel David,Walter Markiewicz,Alon Marmour,Daniel Tzivoni,Elieser Kaplinsky,Natalio Cristal,Yehezkiel Kishon +46 more
TL;DR: This national survey showed that the availability of invasive coronary facilities led to increased use of diagnostic and therapeutic coronary procedures among patients with acute myocardial infarction.
11
Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)
Uri Goldbourt,Uri Goldbourt,Solomon Behar,Solomon Behar,Henrietta Reicher-Reiss,Henrietta Reicher-Reiss,Jacob Agmon,Jacob Agmon,Elieser Kaplinsky,Elieser Kaplinsky,Eran Graft,Eran Graft,Yehezkiel Kishon,Yehezkiel Kishon,Avraham Caspi,Avraham Caspi,Joshua Weisbort,Joshua Weisbort,Lori Mandelzweig,Lori Mandelzweig,Edward Abinader,Edward Abinader,Leon Aharon,Leon Aharon,Shimeon Braun,Shimeon Braun,Daniel David,Daniel David,Michael Flich,Michael Flich,Yaacov Friedman,Yaacov Friedman,Natalio Kristal,Natalio Kristal,Noa Leil,Noa Leil,Walter Markiewicz,Walter Markiewicz,Alon Marmor,Alon Marmor,Abraham Palant,Abraham Palant,Benjamin Pelled,Benjamin Pelled,Babeth Rabinowitz,Babeth Rabinowitz,Leornardo Reisin,Leornardo Reisin,Nathan Roguin,Nathan Roguin,Tiberio Rosenfeld,Tiberio Rosenfeld,Zwi Schlesinger,Zwi Schlesinger,Samuel Sclarovsky,Samuel Sclarovsky,Libi Sherf,Libi Sherf,Daniel Tzivoni,Daniel Tzivoni,Izhar Zahavi,Izhar Zahavi,Monty Zion,Monty Zion,Daniel Brunner +64 more
TL;DR: The hypothesized effect of bezafibrate administration under the aforementioned protocol is to reduce an estimated cumulative end point event incidence of > or = 15% by 20 to 25% over an average follow-up period of 6.25 years.